REGISTERED NUMBER: 16223756 (England and Wales)

Unaudited Financial Statements for the Period 3 February 2025 to 31 March 2026

for

SCG Medical Limited

Page

Balance Sheet

1

FIXED ASSETS

20,000

CURRENT ASSETS

8,678

CREDITORS

Amounts falling due within one year

(7,624

)

NET CURRENT ASSETS

1,054

TOTAL ASSETS LESS CURRENT LIABILITIES

21,054

CAPITAL AND RESERVES

21,054

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

SCG Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

16223756

Registered office:

Solent House

107a Alma Road

Southampton

SO14 6UY

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was NIL.

3.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the period ended 31 March 2026:

£

Dr S C Gunatilake and Dr H J Emery

Balance outstanding at start of period

-

Amounts advanced

5,407

Amounts repaid

(5,407

)

Amounts written off

-

Amounts waived

-

Balance outstanding at end of period

-

4.	FINANCIAL COMMITMENTS

At 31 March 2026, the company had an outstanding commitment of £5,000 to subscribe for further loan notes in connection with its investment in ASI Hampshire A Clinician LLP. This commitment was fulfilled in April 2026.

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 25 October 2026 and were signed on its behalf by:

Dr S C Gunatilake - Director